Home | By sponsor

NATIONAL CENTER OF BIOPRODUCTS

Trials shown by sponsor

Public title Date of Registration State
Biomodulina T - IM - covid-19 - older adult 29/05/2020 Registered
Exploratory study of BMT EV to stimulate immune response in patients with CKD-5 on iterated hemodialysis 28/05/2020 Registered
Pharmacovigilance-VALERGEN-Asthma 27/01/2017 Registered
Subcutaneous immunotherapy with PROLINEM -Asthma- Adults-Fase I 2013-01-04 Registered
Combined Subcutaneous immunotherapy VALERGEN-DP and VALERGEN-BT-Asthma-Adults-Phase II 2012-04-13 Registered
Sublingual immunotherapy with VALERGEN-Asthma-Children-Phase II 2012-04-02 Registered
Evidence of the clinical efficacy of VALERGEN-DS vaccine in asthmatics. 2010-12-09 Registered
Evidence of the clinical efficacy of VALERGEN-BT vaccine in asthmatics 2010-12-09 Registered
Efficacy of VALERGEN-DP sublingual vaccine in asthmatic adults. 2010-12-09 Registered
Evidence of the clinical efficacy of VALERGEN-DP vaccine in asthmatics 2010-12-09 Registered
Efficacy of VALERGEN-BT sublingual vaccine in asthmatic adults. 2010-12-08 Registered
Efficacy of VALERGEN-DS sublingual vaccine in asthmatic adults 2010-12-08 Registered
Efficacy of VALERGENT-BT subcutaneous vaccine in asthmatic adults 2010-12-07 Registered
Efficacy of VALERGEN-DP subcutaneous vaccine in asthmatic adults 2010-12-07 Registered
Efficacy of VALERGEN-DS subcutaneous vaccine in asthmatic adults. 2010-12-07 Registered
BIOMODULINA T in a long-lived population at high risk of COVID-19 infection 19/09/2020 Registered
Combined sublingual immunotherapy VALERGEN-DP and VALERGEN-BT-Asthma-Adults-Phase II 17/02/2017 Registered
Evaluation of Biomodulin T® in patients with HIV/AIDS. Phase II/III. 15/08/2018 Registered
Efficacy of nasal provocation test with VALERGEN-DP, DS and BT 15/04/2019 Registered
Biomodulin T Intramuscular for Thymus Hypoplasia in Children. Phase III 14/08/2017 Registered